Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 3287-3289

  Shubitz, Lisa ^a   Peng, Tao ^a   Perrill, Robert ^a   Simons, Julie ^a   Orsborn, Kris ^a   Galgiani, John N ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCCIDIOIDES IMMITIS VACCINE; RECOMBINANT ANTIGEN 2 PRA; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; INFECTION PREVENTION; LETHALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TREATMENT OUTCOME; VACCINATION; WEIGHT REDUCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, FUNGAL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DISEASE MODELS, ANIMAL; FEMALE; FUNGAL PROTEINS; FUNGAL VACCINES; GLYCOPROTEINS; INJECTIONS, SUBCUTANEOUS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; VACCINATION; VACCINES, SYNTHETIC; WEIGHT LOSS;

EID: 0036259751     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.3287-3289.2002     Document Type: Article

References (26)

1. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or DNA vaccine of a proline-rich antigen
2. In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis
3. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen
4. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
5. Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine
6. Protective immunity in coccidioidomycosis
7. An immunoreactive apoglycoprotein purified from Coccidioides immitis
8. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential
9. Coccidioides immitis isolated from armadillos (Dasypus novemcinctus) in the state of Piaui, northeast Brazil
10. Genetic evidence for the role of the Lv locus in early susceptibility but not IL-10 synthesis in experimental coccidioidomycosis in C57BL mice
11. Extraction of serologic and delayed hypersensitivity antigens from spherules of Coccidioides immitis
12. An arthroconidial-spherule antigen of Coccidioides immitis: Differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination
13. Feline systemic fungal infections
14. Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis
15. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity
16. Nonparametric estimation from incomplete observations
17. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection
18. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice
19. Mucosal vaccination against influenza: Protection of pigs immunized with inactivated virus and ether-split vaccine
20. Immunization of mice with viable Coccidioides immitis
21. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996
22. Constrictive pericarditis secondary to Coccidioides immitis infection in a dog
23. Current concepts: Coccidioidomycosis
24. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona 1994-1997. Incidence, risk factors, and prevention
25. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA
26. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules